Predicting Novel Antitumor Agents: 3D-Pharmacophore Mapping of β-N -biaryl Ether Sulfonamide-Based Hydroxamates as Potentially MMP-2 Inhibitors

2014 ◽  
Vol 33 (9) ◽  
pp. 573-587 ◽  
Author(s):  
Kely Medeiros Turra ◽  
Diogo Pineda Rivelli ◽  
Silvia Berlanga de Moraes Barros ◽  
Kerly Fernanda Mesquita Pasqualoto
2010 ◽  
Vol 24 (2) ◽  
pp. 157-172 ◽  
Author(s):  
Carolina Horta Andrade ◽  
Kerly F. M. Pasqualoto ◽  
Elizabeth I. Ferreira ◽  
Anton J. Hopfinger

2009 ◽  
Vol 49 (4) ◽  
pp. 1070-1078 ◽  
Author(s):  
Carolina H. Andrade ◽  
Kerly F. M. Pasqualoto ◽  
Elizabeth I. Ferreira ◽  
Anton J. Hopfinger

2018 ◽  
Vol 68 (4) ◽  
pp. 860-873
Author(s):  
Milan Jovanović ◽  
Katarina Nikolić ◽  
Žarko Gagić ◽  
Danica Agbaba

The role of vitamin D is implicated in carcinogenesis through numerous biological processes like induction of apoptosis, modulation of immune system inhibition of inflammation and cell proliferation and promotion of cell differentiation. Its use as additional adjuvant drug with cancer treatment may be novel combination for improved outcome of different cancers. Numerous preclinical, epidemiological and clinical studies support the role of vitamin D as an anticancer agent. Anticancer properties of vitamin D have been studied widely (both in vivo and in vitro) among various cancers and found to have promising results. There are considerable data that indicate synergistic potential of calcitriol and antitumor agents. Possible mechanisms for modulatory anticancer activity of vitamin D include its antiproliferative, prodifferentiating, and anti-angiogenic and apoptic properties. Calcitriol reduces invasiveness and metastatic potential of many cancer cells by inhibiting angiogenesis and regulating expression of the key molecules involved in invasion and metastasis. Anticancer activity of vitamin D is synergistic or additive with the antineoplastic actions of several drugs including cytotoxic chemotherapy agents like paclitaxel, docetaxel, platinum base compounds and mitoxantrone. Benefits of addition of vitamin D should be weighed against the risk of its toxicity.


2016 ◽  
Vol 16 (30) ◽  
pp. 3582-3589 ◽  
Author(s):  
Hua Zhou ◽  
Jiang-Qun Cheng ◽  
Zhi-Sen Wang ◽  
Fei-Hu Chen ◽  
Xin-Hua Liu

Sign in / Sign up

Export Citation Format

Share Document